200 related articles for article (PubMed ID: 27169270)
1. [Development of peptidic MERS-CoV entry inhibitors].
Xia S; Wang Q; Liu SW; Lu L; Jiang SB
Yao Xue Xue Bao; 2015 Dec; 50(12):1513-9. PubMed ID: 27169270
[TBL] [Abstract][Full Text] [Related]
2. Identification of a Novel Inhibitor against Middle East Respiratory Syndrome Coronavirus.
Sun Y; Zhang H; Shi J; Zhang Z; Gong R
Viruses; 2017 Sep; 9(9):. PubMed ID: 28906430
[TBL] [Abstract][Full Text] [Related]
3. Protective Effect of Intranasal Regimens Containing Peptidic Middle East Respiratory Syndrome Coronavirus Fusion Inhibitor Against MERS-CoV Infection.
Channappanavar R; Lu L; Xia S; Du L; Meyerholz DK; Perlman S; Jiang S
J Infect Dis; 2015 Dec; 212(12):1894-903. PubMed ID: 26164863
[TBL] [Abstract][Full Text] [Related]
4. MERS-CoV spike protein: a key target for antivirals.
Du L; Yang Y; Zhou Y; Lu L; Li F; Jiang S
Expert Opin Ther Targets; 2017 Feb; 21(2):131-143. PubMed ID: 27936982
[TBL] [Abstract][Full Text] [Related]
5. Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein.
Xia S; Liu Q; Wang Q; Sun Z; Su S; Du L; Ying T; Lu L; Jiang S
Virus Res; 2014 Dec; 194():200-10. PubMed ID: 25451066
[TBL] [Abstract][Full Text] [Related]
6. Mutations in the Spike Protein of Middle East Respiratory Syndrome Coronavirus Transmitted in Korea Increase Resistance to Antibody-Mediated Neutralization.
Kleine-Weber H; Elzayat MT; Wang L; Graham BS; Müller MA; Drosten C; Pöhlmann S; Hoffmann M
J Virol; 2019 Jan; 93(2):. PubMed ID: 30404801
[TBL] [Abstract][Full Text] [Related]
7. Identification of sialic acid-binding function for the Middle East respiratory syndrome coronavirus spike glycoprotein.
Li W; Hulswit RJG; Widjaja I; Raj VS; McBride R; Peng W; Widagdo W; Tortorici MA; van Dieren B; Lang Y; van Lent JWM; Paulson JC; de Haan CAM; de Groot RJ; van Kuppeveld FJM; Haagmans BL; Bosch BJ
Proc Natl Acad Sci U S A; 2017 Oct; 114(40):E8508-E8517. PubMed ID: 28923942
[TBL] [Abstract][Full Text] [Related]
8. The tetraspanin CD9 facilitates MERS-coronavirus entry by scaffolding host cell receptors and proteases.
Earnest JT; Hantak MP; Li K; McCray PB; Perlman S; Gallagher T
PLoS Pathog; 2017 Jul; 13(7):e1006546. PubMed ID: 28759649
[TBL] [Abstract][Full Text] [Related]
9. Species-Specific Colocalization of Middle East Respiratory Syndrome Coronavirus Attachment and Entry Receptors.
Widagdo W; Okba NMA; Li W; de Jong A; de Swart RL; Begeman L; van den Brand JMA; Bosch BJ; Haagmans BL
J Virol; 2019 Aug; 93(16):. PubMed ID: 31167913
[TBL] [Abstract][Full Text] [Related]
10. Antiviral activity against Middle East Respiratory Syndrome coronavirus by Montelukast, an anti-asthma drug.
Gan HJ; Harikishore A; Lee J; Jeon S; Rajan S; Chen MW; Neo JL; Kim S; Yoon HS
Antiviral Res; 2021 Jan; 185():104996. PubMed ID: 33309540
[TBL] [Abstract][Full Text] [Related]
11. Potent MERS-CoV Fusion Inhibitory Peptides Identified from HR2 Domain in Spike Protein of Bat Coronavirus HKU4.
Xia S; Lan Q; Pu J; Wang C; Liu Z; Xu W; Wang Q; Liu H; Jiang S; Lu L
Viruses; 2019 Jan; 11(1):. PubMed ID: 30646495
[TBL] [Abstract][Full Text] [Related]
12. Spread of Mutant Middle East Respiratory Syndrome Coronavirus with Reduced Affinity to Human CD26 during the South Korean Outbreak.
Kim Y; Cheon S; Min CK; Sohn KM; Kang YJ; Cha YJ; Kang JI; Han SK; Ha NY; Kim G; Aigerim A; Shin HM; Choi MS; Kim S; Cho HS; Kim YS; Cho NH
mBio; 2016 Mar; 7(2):e00019. PubMed ID: 26933050
[TBL] [Abstract][Full Text] [Related]
13. Permissivity of Dipeptidyl Peptidase 4 Orthologs to Middle East Respiratory Syndrome Coronavirus Is Governed by Glycosylation and Other Complex Determinants.
Peck KM; Scobey T; Swanstrom J; Jensen KL; Burch CL; Baric RS; Heise MT
J Virol; 2017 Oct; 91(19):. PubMed ID: 28747502
[TBL] [Abstract][Full Text] [Related]
14. Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 Is an Important Surface Attachment Factor That Facilitates Entry of Middle East Respiratory Syndrome Coronavirus.
Chan CM; Chu H; Wang Y; Wong BH; Zhao X; Zhou J; Yang D; Leung SP; Chan JF; Yeung ML; Yan J; Lu G; Gao GF; Yuen KY
J Virol; 2016 Oct; 90(20):9114-27. PubMed ID: 27489282
[TBL] [Abstract][Full Text] [Related]
15. Middle east respiratory syndrome corona virus spike glycoprotein suppresses macrophage responses via DPP4-mediated induction of IRAK-M and PPARγ.
Al-Qahtani AA; Lyroni K; Aznaourova M; Tseliou M; Al-Anazi MR; Al-Ahdal MN; Alkahtani S; Sourvinos G; Tsatsanis C
Oncotarget; 2017 Feb; 8(6):9053-9066. PubMed ID: 28118607
[TBL] [Abstract][Full Text] [Related]
16. MERS-CoV spike protein: Targets for vaccines and therapeutics.
Wang Q; Wong G; Lu G; Yan J; Gao GF
Antiviral Res; 2016 Sep; 133():165-77. PubMed ID: 27468951
[TBL] [Abstract][Full Text] [Related]
17. Safe, high-throughput screening of natural compounds of MERS-CoV entry inhibitors using a pseudovirus expressing MERS-CoV spike protein.
Kim JY; Kim YI; Park SJ; Kim IK; Choi YK; Kim SH
Int J Antimicrob Agents; 2018 Nov; 52(5):730-732. PubMed ID: 29772395
[No Abstract] [Full Text] [Related]
18. Functional analysis of potential cleavage sites in the MERS-coronavirus spike protein.
Kleine-Weber H; Elzayat MT; Hoffmann M; Pöhlmann S
Sci Rep; 2018 Nov; 8(1):16597. PubMed ID: 30413791
[TBL] [Abstract][Full Text] [Related]
19. Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay.
Yamamoto M; Matsuyama S; Li X; Takeda M; Kawaguchi Y; Inoue JI; Matsuda Z
Antimicrob Agents Chemother; 2016 Nov; 60(11):6532-6539. PubMed ID: 27550352
[TBL] [Abstract][Full Text] [Related]
20. Preparation of virus-like particle mimetic nanovesicles displaying the S protein of Middle East respiratory syndrome coronavirus using insect cells.
Kato T; Takami Y; Kumar Deo V; Park EY
J Biotechnol; 2019 Dec; 306():177-184. PubMed ID: 31614169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
